Vardenafil: Clinical Trials

5 trials of Vardenafil, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated. 5 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Completed 4, Terminated 1
Phase 11Completed 1
Phase 31Completed 1

Follow Vardenafil: new trials by email Literature Review of Vardenafil trials Research Report on Vardenafil

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vardenafil Vs Sildenafil for the Treatment of Pulmonary Hypertension of the Newborn
Vardenafil, Sildenafil - PPHN
Phase 1 / Phase 2CompletedDamascus University552023-05-012025-03-06
Does a Nasal Instillation of Vardenafil Normalize the Nasal Potential Difference in Cystic Fibrosis Patients?
Vardenafil, Placebo - Cystic Fibrosis
Phase 2TerminatedCliniques universitaires Saint-Luc- Université Catholique de Louvain52011-10-012019-02-25
Clinical Proof-of-concept Study for the Combination BAY60-4552 / Vardenafil for the Treatment of Erectile Dysfunction Not Sufficiently Responsive to Standard Therapy With PDE5 Inhibitors
BAY60-4552 plus Vardenafil, Vardenafil, Placebo - Erectile Dysfunction
Phase 2CompletedBayer1402010-08-012014-11-04
Diabetes & Vardenafil
Vardenafil, Placebo - Type 2 Diabetes Mellitus (T2DM), Endothelial Dysfunction
Phase 2CompletedAzienda USL Modena542010-03-012014-08-19
Effects of Vardenafil on Clinical Symptoms and Peripheral Blood Flow in Patients With Raynaud's Syndrome
vardenafil, Placebo - Raynaud Syndrome
Phase 2 / Phase 3CompletedUniversity of Cologne572006-11-012011-02-08

Conditions studied

Erectile Dysfunction (2)  ·  Cystic Fibrosis (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Raynaud Disease (1)

Sponsors

Azienda USL Modena (1)  ·  Bayer (1)  ·  Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1)  ·  Damascus University (1)  ·  University of Cologne (1)

Countries

Germany (2)  ·  Italy (2)  ·  Belgium (1)  ·  Finland (1)  ·  France (1)  ·  Netherlands (1)  ·  Spain (1)  ·  Sweden (1)  ·  Syria (1)

Top investigators

Manuela Simoni, MD, PhD (1)  ·  Stephan Rosenkranz, MD (1)

Results publications

PMID 15618584, PMID 18006891

NIH funding

2005 (1)